Literature DB >> 27460000

Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.

Jeong-Yeon Lee1, Gu Kong2.   

Abstract

The epithelial-mesenchymal transition (EMT) is a crucial developmental process by which epithelial cells undergo a mesenchymal phenotypic change. During EMT, epigenetic mechanisms including DNA methylation and histone modifications are involved in the regulation of EMT-related genes. The epigenetic gene silencing of the epithelial marker E-cadherin has been well characterized. In particular, three major transcriptional repressors of E-cadherin, Snail, ZEB, and Twist families, also known as EMT-inducing transcription factors (EMT-TFs), play a crucial role in this process by cooperating with multiple epigenetic modifiers. Furthermore, recent studies have identified the novel epigenetic modifiers that control the expression of EMT-TFs, and these modifiers have emerged as critical regulators of cancer development and as novel therapeutic targets for human cancer. In this review, the diverse functions of EMT-TFs in cancer progression, the cooperative mechanisms of EMT-TFs with epigenetic modifiers, and epigenetic regulatory roles for the expression of EMT-TFs will be discussed.

Entities:  

Keywords:  Chromatin; DNA methylation; EMT; EMT transcription factor; Epigenetics; Histone modification; Human cancer

Mesh:

Substances:

Year:  2016        PMID: 27460000     DOI: 10.1007/s00018-016-2313-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  202 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 3.  The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.

Authors:  Fanyan Meng; Guojun Wu
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals.

Authors:  Shao Wu; Zhi Luo; Peng-Jiu Yu; Hui Xie; Yu-Wen He
Journal:  Biol Chem       Date:  2016-01       Impact factor: 3.915

5.  Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.

Authors:  Fanliang Meng; Guiqin Sun; Mei Zhong; Yanhong Yu; Molly A Brewer
Journal:  Int J Oncol       Date:  2013-05-24       Impact factor: 5.650

Review 6.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 7.  Cancer stem cells: a model in the making.

Authors:  Lauren L Campbell Marotta; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2009-01-21       Impact factor: 5.578

Review 8.  MicroRNA Regulation of Epithelial to Mesenchymal Transition.

Authors:  Mohammed L Abba; Nitin Patil; Jörg Hendrik Leupold; Heike Allgayer
Journal:  J Clin Med       Date:  2016-01-14       Impact factor: 4.241

9.  Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.

Authors:  Aleksandra Markiewicz; Tomasz Ahrends; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Janusz Jaśkiewicz; Jolanta Szade; Wojciech Biernat; Anna J Zaczek
Journal:  J Transl Med       Date:  2012-11-19       Impact factor: 5.531

10.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  48 in total

1.  Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells.

Authors:  Xinmin Dong; Jian Zhang; Fan Yang; Jing Wu; Rui Cai; Tian Wang; Jiren Zhang
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

2.  Runx2 expression: A mesenchymal stem marker for cancer.

Authors:  Maria Teresa Valenti; Paola Serafini; Giulio Innamorati; Anna Gili; Samuele Cheri; Claudio Bassi; Luca Dalle Carbonare
Journal:  Oncol Lett       Date:  2016-09-23       Impact factor: 2.967

Review 3.  Claudin proteins, outside-in signaling, and carcinogenesis.

Authors:  Amar B Singh; Srijayaprakash B Uppada; Punita Dhawan
Journal:  Pflugers Arch       Date:  2016-12-17       Impact factor: 3.657

Review 4.  Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker
Journal:  J Am Coll Cardiol       Date:  2019-01-22       Impact factor: 24.094

5.  Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.

Authors:  Liyang Dong; Chao Ding; Tingting Zheng; Yanan Pu; Jiameng Liu; Wenzhe Zhang; Fei Xue; Ping Kang; Yongbin Ma; Xuefeng Wang; Chaoming Mao
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

6.  Expression and clinical significance of SNAI1 and ZEB1 genes in acute myeloid leukemia patients.

Authors:  Wafaa Ghoneim Shousha; Shimaa Shawki Ramadan; Abeer Salah El-Saiid; Ahmed Essmat Abdelmoneim; Marwa Ahmed Abbas
Journal:  Mol Biol Rep       Date:  2019-05-04       Impact factor: 2.316

Review 7.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

8.  Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.

Authors:  Bin Lian; Hong Li; Yaobang Liu; Dahai Chai; Yali Gao; Yangyang Zhang; Jia Zhou; Jinping Li
Journal:  Breast Cancer       Date:  2020-10-27       Impact factor: 4.239

9.  Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.

Authors:  Marina Rosso; Lara Lapyckyj; María José Besso; Marta Monge; Jaume Reventós; Francesc Canals; Jorge Oswaldo Quevedo Cuenca; María Laura Matos; Mónica Hebe Vazquez-Levin
Journal:  Cancer Metab       Date:  2019-05-09

10.  Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.

Authors:  Lirong Liu; Jianan Zou; Yingjie Guan; Yunhe Zhang; Wei Zhang; Xiaoxu Zhou; Chongxiang Xiong; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2019-08-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.